Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Sandoz Group Ag (0SAN) Share Price

Price 68.36181 on 13-05-2026 at 17:05:25
Change 0.00 0%
Buy 0.00
Sell 0.00
Last Trade: Unknown 4.00 at 67.85602
Day's Volume: 166,435
Last Close: 68.36181
Open: 0.00
ISIN: CH1243598427
Day's Range 0.00 - 0.00
52wk Range: 38.12924 - 72.42
Market Capitalisation: -
VWAP: 68.00421
Shares in Issue: 432.69m

Sandoz Group Ag (0SAN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 4 67.85602 OTC Trade
18:05:24 - 13-May-26
Unknown* 38 67.95579 SI Trade
Negotiated Trade
17:38:28 - 13-May-26
Unknown* 21,871 68.20725 OTC Trade
17:22:25 - 13-May-26
Unknown* 16,595 67.75729 OTC Trade
17:22:24 - 13-May-26
Unknown* 4,311 67.68569 OTC Trade
17:22:24 - 13-May-26
Unknown* 5 68.07004 OTC Trade
17:17:20 - 13-May-26
Unknown* 532 67.82301 OTC Trade
17:17:20 - 13-May-26
Unknown* 46 68.36181 SI Trade
Negotiated Trade
17:11:34 - 13-May-26
Unknown* 72 68.36181 SI Trade
Negotiated Trade
17:11:34 - 13-May-26
Unknown* 309 68.36181 SI Trade
Negotiated Trade
17:11:34 - 13-May-26
See more Sandoz Group Ag trades

Sandoz Group Ag (0SAN) Share Price History

Time period:
to
Date Open High Low Close Volume
12th May 2026 (Tue) 67.21333 67.21333 67.21333 67.21333 312,259
11th May 2026 (Mon) 66.70893 66.70893 66.70893 66.70893 641,383
8th May 2026 (Fri) 66.99068 66.99068 66.99068 66.99068 97,586
7th May 2026 (Thu) 67.12 67.12 67.12 67.12 45,698
6th May 2026 (Wed) 67.16 67.16 67.16 67.16 288,719
5th May 2026 (Tue) 64.85216 64.85216 64.85216 64.85216 144,578
4th May 2026 (Mon) 62.21938 62.21938 62.21938 62.21938 0
1st May 2026 (Fri) 62.21938 62.21938 62.21938 62.21938 0
30th Apr 2026 (Thu) 62.21938 62.21938 62.21938 62.21938 270,001
29th Apr 2026 (Wed) 60.96972 60.96972 60.96972 60.96972 322,252
28th Apr 2026 (Tue) 61.84578 61.84578 61.84578 61.84578 116,735
27th Apr 2026 (Mon) 63.1802 63.1802 63.1802 63.1802 45,564
24th Apr 2026 (Fri) 63.24742 63.24742 63.24742 63.24742 144,916
23rd Apr 2026 (Thu) 64.1012 64.1012 64.1012 64.1012 198,064
22nd Apr 2026 (Wed) 63.70611 63.70611 63.70611 63.70611 274,270
21st Apr 2026 (Tue) 66.07984 66.07984 66.07984 66.07984 144,201
20th Apr 2026 (Mon) 65.87 65.87 65.87 65.87 115,050
17th Apr 2026 (Fri) 65.37782 65.37782 65.37782 65.37782 202,119
16th Apr 2026 (Thu) 66.68 66.68 66.68 66.68 115,102
15th Apr 2026 (Wed) 67.98909 67.98909 67.98909 67.98909 752,959
14th Apr 2026 (Tue) 67.50372 67.50372 67.50372 67.50372 40,524
13th Apr 2026 (Mon) 65.4265 65.4265 65.4265 65.4265 88,827
See more Sandoz Group Ag price history

Sandoz Group Ag (0SAN) Regulatory News

Date Source Headline
12th Aug 2025 6:00 am GNW Sandoz launches renewable energy partnership to cover nearly 90% of electricity demand for European operations
7th Aug 2025 6:00 am GNW Sandoz delivers strong H1 2025 results, with accelerated sales growth in the second quarter
30th Jul 2025 6:15 am GNW Sandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics in-house development and manufacturing capabilities in Toulouse, France
1st Jul 2025 1:56 pm GNW Sandoz further asserts leadership in biosimilars, breaking ground on new Slovenia facility to expand European biosimilar hub and global market reach
2nd Jun 2025 6:00 am GNW Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]
21st May 2025 4:30 pm GNW Sandoz launches Pyzchiva® autoinjector, first commercially available in Europe for ustekinumab biosimilars
30th Apr 2025 6:00 am GNW Sandoz reports Q1 2025 net sales in line with company expectations; full-year guidance confirmed
29th Apr 2025 4:00 pm GNW Sandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indications
15th Apr 2025 12:50 pm GNW Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG
14th Apr 2025 3:00 pm GNW [Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US
See more Sandoz Group Ag regulatory news
FTSE 100 Latest
Value10,325.35
Change60.03

Login to your account

Forgot Password?

Not Registered